NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014 Equity Option [Member]	Sep. 30, 2013 Equity Option [Member]	Sep. 30, 2014 Equity Option [Member]	Sep. 30, 2013 Equity Option [Member]	Sep. 30, 2014 Equity Appreciation Rights Plan [Member] Stock Appreciation Rights (SARs) [Member]	Sep. 30, 2013 Equity Appreciation Rights Plan [Member] Stock Appreciation Rights (SARs) [Member]	Sep. 30, 2014 Equity Appreciation Rights Plan [Member] Stock Appreciation Rights (SARs) [Member]	Sep. 30, 2013 Equity Appreciation Rights Plan [Member] Stock Appreciation Rights (SARs) [Member]	Dec. 31, 2013 Equity Appreciation Rights Plan [Member] Stock Appreciation Rights (SARs) [Member]	Nov. 30, 2010 Equity Appreciation Rights Plan [Member] Stock Appreciation Rights (SARs) [Member] Maximum [Member]
Options
Balance at the beginning of the period(in shares)							216,000
Granted (in shares)					0	0		0
Cancelled (in shares)							(20,000)
Balance at the end of the period (in shares)					196,000		196,000
Exercisable at the end of the period (in shares)					172,918		172,918
Weighted-Average Exercise Price Per Share
Outstanding at the beginning of the period (in dollars per share)							$ 6.46
Cancelled (in dollars per share)							$ 7.46
Outstanding at the end of the period (in dollars per share)					$ 6.36		$ 6.36
Exercisable at the end of the period (in dollars per share)					$ 6.70		$ 6.70
Weighted-Average Remaining Contractual Term
Outstanding at the end of the period							3 years 1 month 28 days
Exercisable at the end of the period							2 years 5 months 9 days
Aggregate Intrinsic Value
Outstanding at the end of the period					$ 50,023		$ 50,023
Exercisable at the end of the period					16,677		16,677
Additional disclosures
Weighted-average fair value of options granted (in dollars per share)							$ 1.65
Compensation expense					7,482	4,444	22,445	9,945	38,000	12,000	119,000	49,000
Unrecognized compensation related to unvested awards					24,000		24,000
Weighted-average period over which unrecognized compensation costs expected to be recognized							1 year 2 months 5 days
Equity Appreciation Rights Plan
Number of common shares authorized														750,000
Vesting period from the base date											3 years
Redemption cash payment period											90 days
Shares granted (in units)											750,000
Accrued compensation									199,000		199,000		81,000
Accrued compensation included in other accrued liabilities									43,000		43,000		29,000
Accrued compensation included in Other Long-Term Liabilities									$ 156,000		$ 156,000		$ 52,000
Awards exercised (in shares)					0	0	0	0
Granted (in shares)					0	0		0
Shares outstanding (in units)									650,000		650,000
Net Income Per Common Share
Options outstanding included in computation of per share amounts (in shares)	26,750	0	26,750	0
Outstanding options included computation of dilutive per-share amounts as effect of all outstanding stock-based awards were antidilutive		169,250		178,139
Reconciliation of basic and diluted share amounts
Basic weighted average common shares outstanding	2,742,992	2,742,992	2,742,992	2,742,992
Diluted weighted average common shares outstanding	2,747,943	2,742,992	2,747,552	2,742,992